Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.


Thursday, 02 February 2017

A practical down-to-earth manual on the whole range of long-term conditions has been written for UK general practice nurses by experts in their field. The book provides a quick way for new practice nurses to learn the basics about long-term conditions and will also be useful to the wider primary healthcare team.

Category: Have You Heard
Friday, 06 October 2017

The new OneTouch Reveal® mobile app is now available in the UK and Ireland. It includes innovative features including blood sugar and activity timelines transformed into quick visual snapshots which allow people with diabetes to see their results, identify trends and get on with their daily life.

Category: Have You Heard
Thursday, 17 January 2019

Leading clinicians and researchers in the USA have proposed a new model for the development of type 2 diabetes which they call ‘Dysglycaemia-based chronic disease’ or DBCD. The four stages of type 2 diabetes have been presented in a recent position statement by the American Association of Clinical Endocrinologists and the American College of Endocrinology.

Category: Have You Heard
Sunday, 13 August 2017

A new blueprint for diabetes care has been published by NHS England in a bid to improve and reduce variation of care.

Category: Have You Heard
Monday, 17 July 2017
Management of type 2 diabetes continues to be very challenging. Adherence with therapy is poor, due in part to the number of medications and the high frequency they need to be taken each day. PillTime is a new system which makes managing medicines easier and is ideal for those on multiple medicines and active lifestyles.
Category: Have You Heard
Friday, 18 December 2009

Glycated haemoglobin – HbA1C, or A1C as it is now being called – should be used to diagnose diabetes, according to a recent recommendation from an international expert committee appointed by the American Diabetes Association, the International Diabetes Federation and the European Association for the Study of Diabetes. We explore the basis for this recommendation, and look at why HbA1C would provide a more accurate measure for diagnosing diabetes than glucose tests and what the change would mean in clinical practice.

Category: Editorial
Wednesday, 23 March 2016

The new NICE Quality Standard provides a valuable framework for healthcare professionals involved in pre- and post-natal care. The new QS covers the management of diabetes and its complications in women who are planning a pregnancy and those already pregnant.

Category: Have You Heard
Thursday, 08 September 2016

NICE has published a new diabetes quality standard for adults featuring seven new and updated statements covering type 2 diabetes prevention, structured education programmes, care and treatment, and prevention and management of foot problems. The new quality standard updates the 2011 version.

Category: Have You Heard
Wednesday, 04 January 2017

Dapagliflozin is now recommended by NICE as part of triple therapy with metformin and a sulfonylurea when two drugs for type 2 diabetes are not providing glycaemic control.

Category: Have You Heard
Thursday, 23 June 2016
Canagliflozin (Invokana™), dapagliflozin (Forxiga™) and empagliflozin (Jardiance™) have received final NICE approval in type 2 diabetes and are now available to patients with type 2 diabetes who cannot tolerate metformin, sulfonylurea or pioglitazone therapy and are not being controlled with diet and exercise.
Category: Have You Heard

Article search and filter